Stock Details
ALC is Alcon Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 71.29$. Average daily volumn in 3 months 967.3k. Market cap 35.08B



Stock symbol : ALC. Exchange : NYSE. Currency : USD
Lastest price : 71.58$. Total volume : 863.27k. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Alcon Inc. (ALC)
Last Price
71.58$
Change
1.69
Volume
863.27k

Previous Close69.89
Open69.49
Day Range69.49-71.61
Bid71.20 x 800
Ask86.00 x 900
Volume863.27k
Average Volume967.3k
Market Cap35.08B
Beta0.60
52 Week Range63.92-88.78
Trailing P/E75.35
Foward P/E29.70
Dividend (Yield %)0.29%
Ex-Dividend Date2022-05-03



Financial Details


According to Alcon Inc.'s financial reports the company's revenue in 2021 were 8.29B an increase( +33.33%) over the years 2020 revenue that were of 6.83B. In 2021 the company's total earnings were 376M while total earnings in 2020 were -531M(-170.81%).


Loading ...



Organization

Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion ... vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Market Cap:
35.08B
Revenue:
8.29B
Total Assets:
28B
Total Cash:
1.57B


News about "Alcon Inc."

Here's Why Investors Should Retain Alcon (ALC) Stock For Now

Source from : Nasdaq - 25 days ago

Alcon Inc. ALC has been gaining from strength across the Surgical and Vision Care franchises. The company exited the first quarter of 2022 with better-than-expected results. Its strategies to ...See details»


Alcon Inc - Stock Ownership ALC

Source from : Morningstar%2c Inc. - 5 days ago

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.See details»


Alcon Inc. (ALC)

Source from : Yahoo Finance - 12 days ago

Why thereโ€™s no relief in sight for soaring oil and gas prices ...See details»


Top 10 Stock Picks of Roberto Mignoneโ€™s Bridger Management

Source from : Insider Monkey - 5 days ago

However, Roberto Mignoneโ€™s Bridger Management still holds 308,168 shares of Ross Stores, Inc. (NASDAQ:ROST), worth more than $27.88 million. Alcon Inc. (NYSE:ALC) creates, produces, and sells goods ...See details»


Alcon: Revisiting The Investment Thesis

Source from : Seeking Alpha - 1 month ago

Alcon Inc. (NYSE:ALC) recently published Q1 FY22 results which came in better than expected. The company maintains a double-digit revenue growth rate and is well on track to achieve its full-year ...See details»


PRO Awards Gold: Best Cross-Channel Campaign 2016-Alconโ€™s Howard and the Amazing Eye Exam

Source from : Chief Marketer - 14 days ago

Alcon had been seeing stagnant sales of its over-the-counter eye-care products. Making matters worse, it was losing shelf space and volume at Walmart, which accounted for one-third of its business.See details»


Volunteers Tackle Yard Work to Help Fort Worth Nonprofit

Source from : NBC DFW - 7 days ago

A team of employees from Fort Worth-based Alcon spent a hot day clearing out a lot next door to a place called The Wish House. The Wish House is the home of the nonprofit A Wish with Wings.See details»


Optometry Professional Market May See a Big Move : Alcon, Haag-Streit, Nidek

Source from : Digital Journal - 14 days ago

Key Players in This Report Include: Bausch & Lomb Inc (Canada), Carl Zeiss Meditec AG (Germany), Alcon Inc (Switzerland), Johnson & Johnson Vision Care Inc. (United States), Essilor International ...See details»


IP Watch: Settlement Another Win for Medinol

Source from : MD&M East - 20 days ago

Abbott and Medinol weren't the only medtech companies talking settlement this month. The previous week, ophthalmology specialists Alcon Inc. (Fort Worth, TX) and Advanced Medical Optics (AMO; Santa ...See details»


New Suit

Source from : Law - 11 days ago

The suit targets Alcon Research LLC and GD Group USA Company, doing business as GD Medical Inc. Medmarc seeks a declaration that it has no duty to defend or indemnify GD in underlying claims ...See details»


Alcon (ALC) Signs EYSUVIS-Buyout Deal With Kala Pharmaceuticals

Source from : Yahoo Finance - 23 days ago

Alcon Inc. ALC recently inked a deal to acquire EYSUVIS (loteprednol etabonate suspension) 0.25% pharmaceutical eye drops from Kala Pharmaceuticals, Inc. The acquisition adds to Alconโ€™s Systane family ...See details»


Ophthalmic Lasers Market is estimated to increase from a valuation of US$ 884.3 Million in 2022

Source from : PharmiWeb - 3 days ago

Pages Report] Technological advancements have deeply penetrated every facet of the healthcare industry, and theย ophthalmic lasers marketย is no exception. Over the years, ophthalmic disorders such as ...See details»


Football Star Cooper Kupp Encourages Eye Allergy Sufferers to Find the Right Tool for the Job with Pataday

Source from : Stockhouse - 28 days ago

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced a partnership with Cooper Kupp, professional football wide receiver and MVP of the โ€œBig ...See details»


Ocular Implant Market Growth is expected to be spectacular by 2030 | By -Carl Zeiss AG, Johnson & Johnson, Alcon Inc

Source from : Digital Journal - 6 days ago

New Jersey, United States-Ocular Implant Market 2022 โ€“ 2030, Size, Share, and Trends Analysis Research Report Segmented with Type, Component, Application, Region, and Forecast The worldwide ...See details»